Healthy Living/WellnessFDA approves AstraZeneca's EPANOVA, adjunct to diet for people with very high triglyceride levels AstraZeneca won the approval of the FDA for Epanova, a new pill for heart diseases. Epanova is a fish oil-based medication that will compete against GlaxoSmithKline’s Lovaza and Amarin’s Vascepa.by Anne Francis
Healthy Living/WellnessUK surgeon accidentally performs vasectomy on man who needs minor procedure. Uh-oh.by Rhodi Lee
Healthy Living/WellnessWeight loss surgery decreases liver damage, mortality in patients with non-alcoholic fatty liverby Anne Francis
Healthy Living/WellnessJust one daily cup of coffee can keep your eyes young, says studyby Judy Mottl
Healthy Living/WellnessBreakthrough fertility treatments, demand for designer babies may 'threaten humanity,' says IVF pioneerby Anne Francis
Healthy Living/WellnessNovartis reports efficacy of Signifor LAR for acromegaly after Phase III trialby Rhodi Lee
Healthy Living/WellnessChildhood nightmares, night terrors may indicate bullying: Studyby Cez Verzosa
Healthy Living/WellnessSeniors should not slow down, walking faster and farther lowers heart attack risks: Studyby Rhodi Lee
ScienceConsumption of sports and energy drinks may prompt teens to make unhealthy choices: Studyby Jim Algar
Healthy Living/WellnessAn aspirin a day prevents heart attack? Not for everyone, says FDAby Anne Francis
Pete Hegseth Reportedly Shared Details of Yemen Attacks in Another Signal Chat That Has His Wife in It